Polymer Capital Management (Us) LLC Biogen Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Biogen Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 3,880 shares of BIIB stock, worth $492,061. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,880Holding current value
$492,061% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,025Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.16 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.02 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.84 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$938 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$593 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...